Daily Stock Analysis, SBOT, Stellar Biotechnologies Inc, priceseries

Stellar Biotechnologies Inc. Daily Stock Analysis
Stock Information
Open
1.11
Close
298098.00
High
298098.00
Low
1.03
Previous Close
3.97
Daily Price Gain
298094.03
YTD High
298098.00
YTD High Date
Jun 28, 2019
YTD Low
0.75
YTD Low Date
Dec 20, 2018
YTD Price Change
298096.60
YTD Gain
21218349.71%
52 Week High
298098.00
52 Week High Date
Jun 28, 2019
52 Week Low
0.75
52 Week Low Date
Dec 20, 2018
52 Week Price Change
298096.60
52 Week Gain
21218349.71%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 4. 2018
1.43
Sep 6. 2018
1.54
2 Trading Days
7.81%
Link
LONG
Jan 2. 2019
0.96
Feb 5. 2019
1.20
23 Trading Days
25.30%
Link
Company Information
Stock Symbol
SBOT
Exchange
NasdaqCM
Company URL
http://www.stellarbiotechnologies.com
Company Phone
(805) 488-2800
CEO
Frank R. Oakes
Headquarters
California
Business Address
332 EAST SCOTT STREET, PORT HUENEME, CA 93041
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001540159
About

Stellar Biotechnologies, Inc. engages in the research, development, manufacture and commercialization of Keyhole Limpet Hemocyanin protein under the brand Stellar KLH. Its product portfolio includes Stellar KLH™ Products, Stellar KLH™ Protein, and Stellar KLH™. ELISA Kits. The Company was founded on June 12, 2007 and is headquartered in Port Hueneme, CA.

Description

Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein primarily in Europe, the United States, and Asia. KLH is an immune-stimulating protein used for generation of antibody and cell-mediated immune responses against disease indications, such as cancer, immune disorders, Alzheimer's, and inflammatory diseases, as well as used for therapeutic vaccine conjugation in immunotherapies. The company also offers in vitro diagnostic kits for preclinical use. It provides its products under the Stellar KLH brand name. The company serves multinational biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers. Stellar Biotechnologies, Inc. is based in Port Hueneme, California.